The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice
- PMID: 11752403
- PMCID: PMC117573
- DOI: 10.1073/pnas.012587699
The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice
Abstract
Identification of mutations in the ABCA1 transporter (ABCA1) as the genetic defect in Tangier disease has generated interest in modulating atherogenic risk by enhancing ABCA1 gene expression. To investigate the role of ABCA1 in atherogenesis, we analyzed diet-induced atherosclerosis in transgenic mice overexpressing human ABCA1 (hABCA1-Tg) and spontaneous lesion formation in hABCA1-Tg x apoE-knockout (KO) mice. Overexpression of hABCA1 in C57BL/6 mice resulted in a unique anti-atherogenic profile characterized by decreased plasma cholesterol (63%), cholesteryl ester (63%), free cholesterol (67%), non-high density lipoprotein (HDL)-cholesterol (53%), and apolipoprotein (apo) B (64%) but markedly increased HDL-cholesterol (2.8-fold), apoA-I (2.2-fold), and apoE (2.8-fold) levels. These beneficial changes in the lipid profile led to significantly lower (65%) aortic atherosclerosis in hABCA1-Tg mice. In marked contrast, ABCA1 overexpression had a minimal effect on the plasma lipid profile of apoE-KO mice and resulted in a 2- to 2.6-fold increase in aortic lesion area. These combined results indicate that overexpression of ABCA1 in C57BL/6 mice on a high cholesterol diet results in an atheroprotective lipoprotein profile and decreased atherosclerosis, and thus provide previously undocumented in vivo evidence of an anti-atherogenic role for the ABCA1 transporter. In contrast, overexpression of ABCA1 in an apoE-KO background led to increased atherosclerosis, further substantiating the important role of apoE in macrophage cholesterol metabolism and atherogenesis. In summary, these results establish that, in the presence of apoE, overexpression of ABCA1 modulates HDL as well as apoB-containing lipoprotein metabolism and reduces atherosclerosis in vivo, and indicate that pharmacological agents that will increase ABCA1 expression may reduce atherogenic risk in humans.
Figures




Similar articles
-
ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice.J Clin Invest. 2001 Jul;108(2):303-9. doi: 10.1172/JCI12517. J Clin Invest. 2001. PMID: 11457883 Free PMC article.
-
ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.J Biol Chem. 2006 Nov 3;281(44):33053-65. doi: 10.1074/jbc.M604526200. Epub 2006 Aug 23. J Biol Chem. 2006. PMID: 16928680
-
Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression.J Lipid Res. 2003 Dec;44(12):2331-8. doi: 10.1194/jlr.M300224-JLR200. Epub 2003 Sep 1. J Lipid Res. 2003. PMID: 12951361
-
Study of ABCA1 function in transgenic mice.Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):965-71. doi: 10.1161/01.ATV.0000055194.85073.FF. Epub 2003 Jan 2. Arterioscler Thromb Vasc Biol. 2003. PMID: 12615681 Review.
-
ATP binding cassette transporter A1--key roles in cellular lipid transport and atherosclerosis.Mol Cell Biochem. 2002 Aug;237(1-2):155-64. doi: 10.1023/a:1016506221047. Mol Cell Biochem. 2002. PMID: 12236582 Review.
Cited by
-
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.J Mol Med (Berl). 2006 Apr;84(4):276-94. doi: 10.1007/s00109-005-0030-4. Epub 2006 Feb 25. J Mol Med (Berl). 2006. PMID: 16501936 Review.
-
Sphingosine kinase-2 prevents macrophage cholesterol accumulation and atherosclerosis by stimulating autophagic lipid degradation.Sci Rep. 2019 Dec 4;9(1):18329. doi: 10.1038/s41598-019-54877-6. Sci Rep. 2019. PMID: 31797978 Free PMC article.
-
Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux.J Biol Chem. 2010 Feb 26;285(9):6316-26. doi: 10.1074/jbc.M109.073601. Epub 2009 Dec 25. J Biol Chem. 2010. PMID: 20037141 Free PMC article.
-
Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.Drugs. 2003;63(18):1907-45. doi: 10.2165/00003495-200363180-00003. Drugs. 2003. PMID: 12930163 Review.
-
Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues.Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6298-303. doi: 10.1073/pnas.092327399. Epub 2002 Apr 23. Proc Natl Acad Sci U S A. 2002. PMID: 11972062 Free PMC article.
References
-
- Gordon D J, Rifkind B M. N Engl J Med. 1989;321:1311–1316. - PubMed
-
- Miller N E. Am Heart J. 1987;113:589–597. - PubMed
-
- Gordon D J, Probstfield J L, Garrison R J, Neaton J D, Castelli W P, Knoke J D, Jr, Jacobs D R, Jr, Bangdiwala S, Tyroler H A. Circulation. 1989;79:8–15. - PubMed
-
- Glomset J A. J Lipid Res. 1968;9:155–167. - PubMed
-
- Fielding C J, Fielding P E. J Lipid Res. 1995;36:211–228. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous